TGF-β downregulates E-cadherin expression via a novel ZEB1-dependent mechanism
- 9 July 2026
- journal article
- Published by Oxford University Press (OUP) in The Journal of Biochemistry
- Vol. 180 (4) , 319-328
Abstract
Zinc finger E-box-binding homeobox 1 (ZEB1) is a core transcription factor regulating epithelial–mesenchymal transition (EMT) and its high expression is associated with malignant cancer phenotypes and poor prognosis. ZEB1 mediates the downregulation of E-cadherin (encoded by CDH1) as a hallmark of cells undergoing EMT. We previously identified two distinct modes of E-cadherin downregulation by ZEB1, namely basal repression and stimulus-dependent repression. The current study aimed to investigate the mechanisms responsible for stimulus-dependent repression induced by transforming growth factor-β (TGF-β) using ZEB1-knockout cells. Knockout of ZEB1 resulted in upregulation of basal E-cadherin expression and attenuation of its downregulation following TGF-β treatment. TGF-β-induced E-cadherin downregulation required Smad3 signalling, but did not involve upregulation of ZEB1 expression, suggesting functional modulation of ZEB1. C-terminal binding proteins were required for basal repression but not for TGF-β-induced downregulation. Consistently, basal repression of CDH1 by ZEB1, but not TGF-β-induced downregulation, was associated with histone deacetylation in the CDH1 regulatory regions; however, both processes required histone deacetylase activity. Histone deacetylase may therefore play a role in regulating the expression or function of factor(s) required for TGF-β-induced CDH1 downregulation. These results suggest that TGF-β downregulates E-cadherin expression via a novel ZEB1-dependent mechanism.Keywords
Funding Information
- the Japan Society for the Promotion of Science (JSPS) KAKENHI (21K15371, 21H02762 and 23K21385)
This publication has 43 references indexed in Scilit:
- Receptor-activated transcription factors and beyond: multiple modes of Smad2/3-dependent transmission of TGF-β signalingJournal of Biological Chemistry, 2024
- Re-Evaluating E-Cadherin and β-CateninThe American Journal of Pathology, 2018
- The Role of E-Cadherin as a Prognostic Biomarker in Head and Neck Squamous Carcinoma: A Systematic Review and Meta-AnalysisMolecular Diagnosis & Therapy, 2018
- The EMT-activator Zeb1 is a key factor for cell plasticity and promotes metastasis in pancreatic cancerNature Cell Biology, 2017
- EMT: 2016Cell, 2016
- Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancerNature, 2015
- MCRIP1, an ERK Substrate, Mediates ERK-Induced Gene Silencing during Epithelial-Mesenchymal Transition by Regulating the Co-Repressor CtBPMolecular Cell, 2015
- δEF1 associates with DNMT1 and maintains DNA methylation of the E‐cadherin promoter in breast cancer cellsCancer Medicine, 2014
- The ZEB/miR‐200 feedback loop—a motor of cellular plasticity in development and cancer?EMBO Reports, 2010
- Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinomain situThe Journal of Pathology, 1997